Department of Radiology, Soonchunhyang University Bucheon Hospital, Bucheon, Korea.
Department of Neurology, Soonchunhyang University Bucheon Hospital, Bucheon, Korea.
PLoS One. 2020 Apr 2;15(4):e0231010. doi: 10.1371/journal.pone.0231010. eCollection 2020.
To evaluate the real-world diagnostic performance of high-resolution susceptibility-weighted imaging (HR-SWI) and investigate whether the reader's predictions can be used to find cases where HR-SWI finding and final clinical diagnosis matched.
This retrospective study enrolled patients with suspected Parkinsonism (n = 48) or volunteers with other intracranial pathologies (n = 31) who underwent brain magnetic resonance imaging (MRI) including HR-SWI, which was used to evaluate nigrosome 1 (NG1). All patients with suspected Parkinsonism underwent N-3-fluoropropyl-2-carbomethoxy-3-4-iodophenyl nortropane (FP-CIT) positron emission tomography and a clinical diagnosis was made by a neurologist. The HR-SWI data were qualitatively analyzed by two independent reviewers. A consensus reading was performed and a diagnostic confidence score was assigned. According to final clinical diagnosis, diagnostic sensitivity, specificity, and accuracy were calculated. Receiver operating characteristic (ROC) curve analysis was used to examine whether the diagnostic confidence score could be used to identify HR-SWI finding-final clinical diagnosis matched cases.
Of the 48 patients with suspected Parkinsonism, 31 were diagnosed with idiopathic Parkinson's disease, and three with multiple system atrophy. The remaining 14 patients were included in the disease control group. Of the 31 volunteers, 10 subjects were excluded due to possibility of nigrostriatal degeneration and finally 21 subjects were enrolled as controls with non-Parkinsonism pathology (non-PD control). After consensus reading, 25 subjects were classified as true positive and 28 as true negative, according to HR-SWI findings. The calculated diagnostic sensitivity, specificity, and accuracy were 73.5%, 80.0%, and 76.8%, respectively. With using diagnostic concordance score, the area under the ROC curve for the detection of concordance case was 0.83 (95% CI: 0.72-0.91, p < 0.05).
The diagnostic performance of NG1 detection using HR-SWI with 3T MRI was within acceptable range. Using the reader's diagnostic confidence could be helpful to find cases which HR-SWI finding and final clinical conclusion match. So HR-SWI may be of added value in the evaluation of suspected Parkinsonism.
评估高分辨率磁敏感加权成像(HR-SWI)的真实世界诊断性能,并研究读者的预测是否可用于发现 HR-SWI 结果与最终临床诊断相符的病例。
本回顾性研究纳入了疑似帕金森病患者(n=48)或其他颅内病变志愿者(n=31),这些患者均接受了包括 HR-SWI 的脑部磁共振成像(MRI)检查,用于评估黑质 1 区(NG1)。所有疑似帕金森病患者均接受 N-3-氟丙基-2-羧甲基-3-4-碘代苯托烷(FP-CIT)正电子发射断层扫描,由神经科医生做出临床诊断。两名独立的观察者对 HR-SWI 数据进行定性分析。进行了共识阅读,并分配了诊断置信度评分。根据最终临床诊断计算诊断灵敏度、特异性和准确性。采用受试者工作特征(ROC)曲线分析,以评估诊断置信度评分是否可用于识别 HR-SWI 结果与最终临床诊断相符的病例。
在 48 例疑似帕金森病患者中,31 例被诊断为特发性帕金森病,3 例为多系统萎缩。其余 14 例患者归入疾病对照组。在 31 名志愿者中,由于存在黑质纹状体变性的可能性,10 名受试者被排除,最终纳入 21 名非帕金森病病理的志愿者作为对照组(非 PD 对照组)。经过共识阅读,根据 HR-SWI 结果,25 例被归类为真阳性,28 例为真阴性。计算得出的诊断灵敏度、特异性和准确性分别为 73.5%、80.0%和 76.8%。使用诊断一致性评分,检测一致性病例的 ROC 曲线下面积为 0.83(95%CI:0.72-0.91,p<0.05)。
使用 3T MRI 的 HR-SWI 检测 NG1 的诊断性能在可接受的范围内。使用读者的诊断信心可能有助于发现 HR-SWI 结果与最终临床结论相符的病例。因此,HR-SWI 可能对评估疑似帕金森病具有附加价值。